Skip to main navigation Skip to search Skip to main content

Apolipoprotein E ε4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics

  • Lucia Olarte
  • , Nicole Schupf
  • , Joseph H. Lee
  • , Ming Xin Tang
  • , Vincent Santana
  • , Jennifer Williamson
  • , Prashanthi Maramreddy
  • , Benjamin Tycko
  • , Richard Mayeux
  • Columbia University
  • New York State Office for People with Developmental Disabilities

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Abstract

Background: The primary effect of the apolipoprotein E ε4 (APOE ε4) allele is on the age at onset of Alzheimer disease (AD). Objective: To investigate whether the presence of the APOE ε4 allele can account for the earlier age at onset of familial AD (FAD) compared with sporadic AD (SAD). Design: Population-based, case series ascertained in a prospective study of aging and dementia in Medicare recipients aged 65 years or older. Setting: Clinics in northern Manhattan and in the Dominican Republic and Puerto Rico. Participants: There were 680 Caribbean Hispanic subjects: 111 patients with FAD, with at least 1 family member with dementia; 163 patients with SAD; and 406 elderly persons without dementia or other illnesses. Main Outcome Measure: Age at onset of dementia was examined in relation to frequency of APOE ε4. Sex, education, and medical risk factors for stroke, hypertension, diabetes, and heart disease were examined as effect modifiers. Results: The mean age at onset of AD was significantly lower in FAD than in SAD, and a statistically significant dose effect of the APOE ε4 allele was present for age at onset in FAD (P = .001) but not in SAD. The age at onset in patients homozygous for the APOE ε4 allele with FAD and SAD was similar. Compared with SAD, the major difference was younger age at onset in patients with FAD who were heterozygous for the APOE ε4 allele and those without an APOE ε4 allele. Conclusions: Apolipoprotein E ε4 had a consistent lowering effect on age at onset of FAD, but this was attenuated in SAD. This suggests that among individuals with a family history of AD and the APOE å4 allele, additional genetic or environmental factors may accelerate the onset of dementia.

Original languageEnglish
Pages (from-to)1586-1590
Number of pages5
JournalArchives of Neurology
Volume63
Issue number11
DOIs
StatePublished - Nov 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Apolipoprotein E ε4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics'. Together they form a unique fingerprint.

Cite this